Assessment of Tp-e Interval and QT Dispersion in Patients With Celiac Disease in Children (CEL-QT)

August 18, 2026 updated by: Merna Fayez (Faiz) Shenoda

Assessment of Tp-e Interval and QT Dispersion in Patients With Celiac Disease in Children at Sohag University Hospital

This is a study at sohag university hospital aim to demonstrate if children with celiac disease have more sensitivity of their myocardium to arrhythmia compared to healthy children.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

This study is a case control aims to :

  • Assess Tp-e interval, Tp e/QTc ratio , Tp-e/QT ratio and QT dispersion in patients with celiac disease attending Sohag University Hospital
  • Compare Tp e interval, Tp e/QT ratio ,Tp e/QTc ratio and and QT dispersion between children with celiac disease and healthy controls.
  • With there parameters demonstrate if children with celiac disease have more sensitivity of their myocardium to arrhythmia compared to healthy children.

Study Type

Observational

Enrollment (Estimated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

All children who confirmed diagnosed as celiac disease who visit sohag University Hospital at time of study under 18 years old and don't have any associated disease cross matched with same number of healthy children at the same age and not have any other problems at the duration of study.

Description

Inclusion Criteria:

  • All children who confirmed diagnosed as celiac disease who visit sohag University Hospital

Exclusion Criteria:

cardiac disease.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
children with celiac disease
children from birth to 18 years old diagnosed with celiac disease visit sohag university hospital
Other: No intervention (observational study)
the study don't need intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of Tp-e Interval
Time Frame: 1 year
Assessment of Tp-e Interval in children diagnosed with celiac disease and compare it with healthy children
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of QT dispersion
Time Frame: 1 year
Assessment of QT dispersion in children diagnosed with celiac disease and compare it with healthy children
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Merna Fayez (Faiz) Shenoda

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

August 1, 2026

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

July 1, 2027

Study Registration Dates

First Submitted

August 14, 2026

First Submitted That Met QC Criteria

August 18, 2026

First Posted (Actual)

August 21, 2026

Study Record Updates

Last Update Posted (Actual)

August 21, 2026

Last Update Submitted That Met QC Criteria

August 18, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • soh-Med-26-7-20Ms

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

individuals participant data will not be shared due to privacy protection policies at Sohag university Hospital

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe